Retatrutide
US$ 23.46
tirzepatide composition Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Overview of Tirzepatide and Semaglutide
Description
The GLP-1 boom is making people desperate to get the pricey weight-loss drugs
Heres an in-depth look at
Tirzepatide 30mg a dual GIP & GLP-1 receptor agonist studied for advanced research into glucose control, weight management, and metabolic health.
It demonstrates that the (seemingly magical) drug down-regulates specific proteins associated with cardiovascular disease (and lots of other nasties) well beyond what would be predicted by weight loss and glycemic control
ACCESS GLP-1 Program: Personalized care to improve wellness, support balanced blood sugar, and promote healthy, sustainable habits.